Clinical Value of Circulating microRNAs in Diagnosis and Prognosis of Pancreatic Cancer: A Systematic Review
- PMID: 37746488
- PMCID: PMC10513118
- DOI: 10.7759/cureus.43931
Clinical Value of Circulating microRNAs in Diagnosis and Prognosis of Pancreatic Cancer: A Systematic Review
Abstract
Pancreatic cancer (PC) is one of the most common cancers and has a high mortality rate due to high invasiveness and rapid progression. Microribonucleic acid (microRNA) plays an essential role in diagnosing PC in the early stages, which improves the five-year survival rate. This systematic review aims to highlight the different subtypes of serum and plasma microRNAs and panel-based assays of microRNAs and how they play a crucial role in the diagnosis and prognosis of PC as a high-sensitive and specific novel biomarker. Following the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines, an in-depth search was performed by using regular keywords and major Medical Subject Heading (MeSH) keywords in PubMed (MEDLINE), PubMed Central, Google Scholar, Science Direct, and Cochrane Library for articles related to this topic and published between 2013 and 2023, up to April 18, 2023. Further eligibility criteria and quality assessment tools were employed to assess the risk of bias, and 13 articles were finalized to be used in this review. The chosen articles included five cross-sectional studies, six systematic reviews and meta-analyses, and two literature reviews. This review provides strong evidence of the usage of microRNA for early diagnosis. It can also be used to exclude differential diagnoses of other diseases, and its prognostic value for determining metastasis and therapeutic efficacy in PC patients. Also, combining microRNA panels with carbohydrate antigen 19.9 (CA19-9) improves the sensitivity and specificity of microRNA as a biomarker.
Keywords: circulating exosomes; ductal pancreatic carcinoma; highly sensitive biomarker; highly specific biomarker; microrna; mir; molecular biomarker; pancreatic cancer; pancreatic cancer diagnosis; pancreatic cancer prognosis.
Copyright © 2023, Senaratne et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- The International Study Group of Pancreatic Surgery definition of delayed gastric emptying and the effects of various surgical modifications on the occurrence of delayed gastric emptying after pancreatoduodenectomy. Panwar R, Pal S. Hepatobiliary Pancreat Dis Int. 2017;16:353–363. - PubMed
-
- The global burden of pancreatic cancer. Lippi G, Mattiuzzi C. https://doi.org/10.5114/aoms.2020.94845. Arch Med Sci. 2020;16:820–824. - PMC - PubMed
-
- Survival Rates for Pancreatic Cancer. [ Apr; 2023 ]. 2023. https://www.cancer.org/cancer/types/pancreatic-cancer/detection-diagnosi... https://www.cancer.org/cancer/types/pancreatic-cancer/detection-diagnosi...
-
- Cancer Stat Facts: Pancreatic cancer. [ May; 2023 ]. 2023. https://seer.cancer.gov/statfacts/html/pancreas.html https://seer.cancer.gov/statfacts/html/pancreas.html
-
- More deaths from pancreatic cancer than breast cancer in the EU by 2017. Ferlay J, Partensky C, Bray F. https://doi.org/10.1080/0284186X.2016.1197419. Acta Oncol. 2016;55:1158–1160. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous